The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) on Monday announced that its CU-Med Biobank has received international accreditation, noting the achievement is expected to help Hong Kong become a key regional hub of biomedical research.
The CU-Med Biobank set up in 2019 recently received international accreditation from the American Association for Laboratory Accreditation (A2LA), which is an endorsement of its high standards, the CUHK said in a statement.
Together with one in South Korea, the CU-Med Biobank is one of only two biobanks that fulfill the required international standards in the Asia-Pacific region, according to it. The biobank will be a driving force for the development of biomedicine in the Guangdong-Hong Kong-Macao Greater Bay Area, and lead Hong Kong to become an important biomedical research hub in the region, said the CUHK.
Click to read more.